Cargando…
3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular Inflammation
3K3A-Activated Protein C (APC) is a recombinant variant of the physiological anticoagulant APC with pleiotropic cytoprotective properties albeit without the bleeding risks. The anti-inflammatory activities of 3K3A-APC were demonstrated in multiple preclinical injury models, including various neurolo...
Autores principales: | Palevski, Dahlia, Ben-David, Gil, Weinberger, Yehonatan, Haj Daood, Rabeei, Fernández, José A., Budnik, Ivan, Levy-Mendelovich, Sarina, Kenet, Gili, Nisgav, Yael, Weinberger, Dov, Griffin, John H., Livnat, Tami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694680/ https://www.ncbi.nlm.nih.gov/pubmed/36430674 http://dx.doi.org/10.3390/ijms232214196 |
Ejemplares similares
-
3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the Retina
por: Weinberger, Yehonatan, et al.
Publicado: (2023) -
Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction
por: Livnat, Tami, et al.
Publicado: (2021) -
Possible involvement of NETosis in inflammatory processes in the eye: Evidence from a small cohort of patients
por: Barliya, Tilda, et al.
Publicado: (2017) -
Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
por: Levy-Mendelovich, Sarina, et al.
Publicado: (2021) -
Factor VIII inhibitors in hemophilia A treated with emicizumab: longitudinal follow-up of outcomes
por: Levy-Mendelovich, Sarina, et al.
Publicado: (2023)